Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

829 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HEART UK consensus statement on Lipoprotein(a): A call to action.
Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee. Cegla J, et al. Among authors: datta d. Atherosclerosis. 2019 Dec;291:62-70. doi: 10.1016/j.atherosclerosis.2019.10.011. Epub 2019 Oct 14. Atherosclerosis. 2019. PMID: 31704552 Free article. Review.
HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.
France M, Rees A, Datta D, Thompson G, Capps N, Ferns G, Ramaswami U, Seed M, Neely D, Cramb R, Shoulders C, Barbir M, Pottle A, Eatough R, Martin S, Bayly G, Simpson B, Halcox J, Edwards R, Main L, Payne J, Soran H; for HEART UK Medical Scientific and Research Committee. France M, et al. Among authors: datta d. Atherosclerosis. 2016 Dec;255:128-139. doi: 10.1016/j.atherosclerosis.2016.10.017. Epub 2016 Nov 5. Atherosclerosis. 2016. PMID: 27839699 Free article. Review.
Corrigendum to "Lipoprotein apheresis efficacy, challenges and outcomes: A descriptive analysis from the UK Lipoprotein Apheresis Registry, 1989-2017" [Atherosclerosis 290 (November 2019) 44-51].
Pottle A, Thompson G, Barbir M, Bayly G, Cegla J, Cramb R, Dawson T, Eatough R, Kale V, Neuwirth C, Nicholson K, Payne J, Scott J, Soran H, Walji S, Watkins S, Weedon H, Datta DBN. Pottle A, et al. Atherosclerosis. 2020 Feb;294:16. doi: 10.1016/j.atherosclerosis.2019.12.015. Epub 2020 Jan 11. Atherosclerosis. 2020. PMID: 31935635 No abstract available.
Corrigendum to "HEART UK consensus statement on Lipoprotein(a): A call to action" [Atherosclerosis 291 (2019) 62-70].
Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee. Cegla J, et al. Among authors: datta d. Atherosclerosis. 2020 Mar;296:48. doi: 10.1016/j.atherosclerosis.2020.01.019. Epub 2020 Feb 1. Atherosclerosis. 2020. PMID: 32018073 No abstract available.
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK.
Iqbal Z, Ho JH, Adam S, France M, Syed A, Neely D, Rees A, Khatib R, Cegla J, Byrne C, Qureshi N, Capps N, Ferns G, Payne J, Schofield J, Nicholson K, Datta D, Pottle A, Halcox J, Krentz A, Durrington P, Soran H; Heart UK's Medical Scientific and Research Committee. Iqbal Z, et al. Among authors: datta d. Atherosclerosis. 2020 Nov;313:126-136. doi: 10.1016/j.atherosclerosis.2020.09.008. Epub 2020 Sep 15. Atherosclerosis. 2020. PMID: 33045618 Free PMC article. Review.
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options.
Bashir B, Ho JH, Downie P, Hamilton P, Ferns G, Datta D, Cegla J, Wierzbicki AS, Dawson C, Jenkinson F, Delaney H, Mansfield M, Teoh Y, Miedzybrodzka Z, Haso H, Durrington PN, Soran H. Bashir B, et al. Among authors: datta d. Metabolites. 2023 Apr 30;13(5):621. doi: 10.3390/metabo13050621. Metabolites. 2023. PMID: 37233662 Free PMC article. Review.
Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis.
Qureshi N, Woods B, Neves de Faria R, Saramago Goncalves P, Cox E, Leonardi Bee J, Condon L, Weng S, Akyea RK, Iyen B, Roderick P, Humphries SE, Rowlands W, Watson M, Haralambos K, Kenny R, Datta D, Miedzybrodzka Z, Byrne C, Kai J. Qureshi N, et al. Among authors: datta d. Health Technol Assess. 2023 Oct;27(16):1-140. doi: 10.3310/CTMD0148. Health Technol Assess. 2023. PMID: 37924278 Free PMC article.
The future of clinical lipidology in the UK.
Cegla J, Datta D, Rees A, Soran H, Thompson G. Cegla J, et al. Among authors: datta d. Clin Med (Lond). 2024 Mar;24(2):100026. doi: 10.1016/j.clinme.2024.100026. Epub 2024 Feb 16. Clin Med (Lond). 2024. PMID: 38369129 Free PMC article. No abstract available.
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).
Bashir B, Kwok S, Wierzbicki AS, Jones A, Dawson C, Downie P, Jenkinson F, Delaney H, Mansfield M, Datta D, Teoh Y, Hamilton P, Forrester N, O'Sullivan D, Ferdousi M, Durrington PN, AbdelRazik A, Gallo A, Moulin P, Soran H. Bashir B, et al. Among authors: datta d. Atherosclerosis. 2024 Apr;391:117476. doi: 10.1016/j.atherosclerosis.2024.117476. Epub 2024 Feb 10. Atherosclerosis. 2024. PMID: 38447437
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry.
Bashir B, Downie P, Forrester N, Wierzbicki AS, Dawson C, Jones A, Jenkinson F, Mansfield M, Datta D, Delaney H, Teoh Y, Hamilton P, Ferdousi M, Kwok S, O'Sullivan D, Wang J, Hegele RA, Durrington PN, Soran H. Bashir B, et al. Among authors: datta d. Arterioscler Thromb Vasc Biol. 2024 Nov;44(11):2334-2346. doi: 10.1161/ATVBAHA.124.320955. Epub 2024 Sep 5. Arterioscler Thromb Vasc Biol. 2024. PMID: 39234690 Free PMC article.
829 results